• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮应用 3 种高蛋白结合度紫外线滤光剂的 ADME 特征描述和 PBK 模型开发。

ADME characterization and PBK model development of 3 highly protein-bound UV filters through topical application.

机构信息

Unilever Safety and Environmental Assurance Centre, Sharnbrook MK44 1LQ, UK.

Cosmetics Europe, Auderghem 1160, Belgium.

出版信息

Toxicol Sci. 2023 Oct 30;196(1):1-15. doi: 10.1093/toxsci/kfad081.

DOI:10.1093/toxsci/kfad081
PMID:37584694
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10613959/
Abstract

Estimating human exposure in the safety assessment of chemicals is crucial. Physiologically based kinetic (PBK) models which combine information on exposure, physiology, and chemical properties, describing the absorption, distribution, metabolism, and excretion (ADME) processes of a chemical, can be used to calculate internal exposure metrics such as maximum concentration and area under the concentration-time curve in plasma or tissues of a test chemical in next-generation risk assessment. This article demonstrates the development of PBK models for 3 UV filters, specifically octyl methoxycinnamate, octocrylene, and 4-methylbenzylidene camphor. The models were parameterized entirely based on data obtained from in vitro and/or in silico methods in a bottom-up modeling approach and then validated based on human dermal pharmacokinetic (PK) data. The 3 UV filters are "difficult to test" in in vitro test systems due to high lipophilicity, high binding affinity for proteins, and nonspecific binding, for example, toward plastic. This research work presents critical considerations in ADME data generation, interpretation, and parameterization to assure valid PBK model development to increase confidence in using PBK modeling to help make safety decisions in the absence of human PK data. The developed PBK models of the 3 chemicals successfully simulated the plasma concentration profiles of clinical PK data following dermal application, indicating the reliability of the ADME data generated and the parameters determined. The study also provides insights and lessons learned for characterizing ADME and developing PBK models for highly lipophilic and protein-bound chemicals in the future.

摘要

估算化学品安全评估中的人体暴露量至关重要。生理相关的动力学 (PBK) 模型结合了暴露、生理学和化学特性的信息,描述了化学物质的吸收、分布、代谢和排泄 (ADME) 过程,可以用于计算下一代风险评估中测试化学物质的血浆或组织中的最大浓度和浓度-时间曲线下面积等内部暴露指标。本文展示了 3 种紫外线滤光剂(辛基甲氧基肉桂酸酯、奥克立林和 4-甲基亚苄基樟脑)的 PBK 模型的开发。这些模型完全基于体外和/或计算方法的数据,采用自下而上的建模方法进行参数化,然后基于人体皮肤药代动力学 (PK) 数据进行验证。由于亲脂性高、与蛋白质的结合亲和力高以及与塑料等非特异性结合等原因,这 3 种紫外线滤光剂在体外测试系统中“难以测试”。这项研究工作提出了在 ADME 数据生成、解释和参数化方面的关键考虑因素,以确保有效开发 PBK 模型,提高在缺乏人体 PK 数据的情况下使用 PBK 模型进行安全性决策的信心。开发的 3 种化学物质的 PBK 模型成功模拟了皮肤应用后临床 PK 数据的血浆浓度曲线,表明 ADME 数据生成和确定的参数具有可靠性。该研究还为未来高度亲脂性和与蛋白质结合的化学物质的 ADME 特征描述和 PBK 模型开发提供了见解和经验教训。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44fc/10613959/a279f1a70866/kfad081f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44fc/10613959/efcb10dad570/kfad081f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44fc/10613959/8d70794bd329/kfad081f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44fc/10613959/a912abe1367e/kfad081f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44fc/10613959/03a53587d643/kfad081f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44fc/10613959/8d3430460edf/kfad081f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44fc/10613959/48a8c9797a42/kfad081f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44fc/10613959/a279f1a70866/kfad081f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44fc/10613959/efcb10dad570/kfad081f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44fc/10613959/8d70794bd329/kfad081f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44fc/10613959/a912abe1367e/kfad081f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44fc/10613959/03a53587d643/kfad081f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44fc/10613959/8d3430460edf/kfad081f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44fc/10613959/48a8c9797a42/kfad081f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44fc/10613959/a279f1a70866/kfad081f7.jpg

相似文献

1
ADME characterization and PBK model development of 3 highly protein-bound UV filters through topical application.经皮应用 3 种高蛋白结合度紫外线滤光剂的 ADME 特征描述和 PBK 模型开发。
Toxicol Sci. 2023 Oct 30;196(1):1-15. doi: 10.1093/toxsci/kfad081.
2
Use of Physiologically-Based Kinetics Modelling to Reliably Predict Internal Concentrations of the UV Filter, Homosalate, After Repeated Oral and Topical Application.使用基于生理学的动力学模型来可靠预测紫外线过滤剂胡莫柳酯在反复口服和局部应用后的体内浓度。
Front Pharmacol. 2022 Jan 4;12:802514. doi: 10.3389/fphar.2021.802514. eCollection 2021.
3
PBK modelling of topical application and characterisation of the uncertainty of C estimate: A case study approach.局部应用的 PBK 建模和 C 估计不确定性的特征描述:案例研究方法。
Toxicol Appl Pharmacol. 2022 May 1;442:115992. doi: 10.1016/j.taap.2022.115992. Epub 2022 Mar 25.
4
Assessment of the predictive capacity of a physiologically based kinetic model using a read-across approach.使用类推法评估基于生理学的动力学模型的预测能力。
Comput Toxicol. 2021 May;18:100159. doi: 10.1016/j.comtox.2021.100159.
5
A generic avian physiologically-based kinetic (PBK) model and its application in three bird species.通用禽类生理动力学(PBK)模型及其在三种鸟类中的应用。
Environ Int. 2022 Nov;169:107547. doi: 10.1016/j.envint.2022.107547. Epub 2022 Sep 26.
6
Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment.为了在化学风险评估中更好地利用和接受通用基于生理的动力学 (PBK) 模型进行体外-体内外推 (IVIVE),实现最佳效果。
Arch Toxicol. 2022 Dec;96(12):3407-3419. doi: 10.1007/s00204-022-03356-5. Epub 2022 Sep 5.
7
Application of physiologically based kinetic (PBK) modelling in the next generation risk assessment of dermally applied consumer products.生理动力学(PBK)模型在经皮应用消费品下一代风险评估中的应用。
Toxicol In Vitro. 2020 Mar;63:104746. doi: 10.1016/j.tiv.2019.104746. Epub 2019 Dec 16.
8
Next generation risk assessment for occupational chemical safety - A real world example with sodium-2-hydroxyethane sulfonate.下一代职业化学安全风险评估 - 以羟乙磺酸单钠盐为例的真实世界研究。
Toxicology. 2024 Aug;506:153835. doi: 10.1016/j.tox.2024.153835. Epub 2024 Jun 8.
9
Predictive performance of next generation human physiologically based kinetic (PBK) models based on in vitro and in silico input data.基于体外和计算机模拟输入数据的下一代人体生理动力学(PBK)模型的预测性能。
ALTEX. 2022;39(2):221–234. doi: 10.14573/altex.2108301. Epub 2022 Jan 19.
10
Systematic evaluation of high-throughput PBK modelling strategies for the prediction of intravenous and oral pharmacokinetics in humans.系统评价高通量 PBK 建模策略在预测人体静脉内和口服药代动力学中的应用。
Arch Toxicol. 2024 Aug;98(8):2659-2676. doi: 10.1007/s00204-024-03764-9. Epub 2024 May 9.

引用本文的文献

1
Comparative Efficacy of Tumor Microenvironment-responsive Nanotherapeutics Targeting PSD95/Discs-large/ZO-1 Binding Kinase in Different Histological Subgroups of Medulloblastoma.靶向髓母细胞瘤不同组织学亚组中PSD95/盘状大蛋白/紧密连接蛋白1结合激酶的肿瘤微环境响应性纳米疗法的比较疗效
Int J Med Sci. 2024 Nov 11;21(15):3018-3033. doi: 10.7150/ijms.97992. eCollection 2024.

本文引用的文献

1
New Methodology for Determining Plasma Protein Binding Kinetics Using an Enzyme Reporter Assay Coupling with High-Resolution Mass Spectrometry.一种结合高分辨率质谱的酶报告检测法测定血浆蛋白结合动力学的新方法
Anal Chem. 2023 Feb 28;95(8):4086-4094. doi: 10.1021/acs.analchem.2c04864. Epub 2023 Feb 15.
2
PBK modelling of topical application and characterisation of the uncertainty of C estimate: A case study approach.局部应用的 PBK 建模和 C 估计不确定性的特征描述:案例研究方法。
Toxicol Appl Pharmacol. 2022 May 1;442:115992. doi: 10.1016/j.taap.2022.115992. Epub 2022 Mar 25.
3
The SCCS Notes of Guidance for the testing of cosmetic ingredients and their safety evaluation, 11th revision, 30-31 March 2021, SCCS/1628/21.
SCCS 化妆品成分测试和安全性评估指导原则注释,第 11 修订版,2021 年 3 月 30 日至 31 日,SCCS/1628/21。
Regul Toxicol Pharmacol. 2021 Dec;127:105052. doi: 10.1016/j.yrtph.2021.105052. Epub 2021 Oct 13.
4
A New Guidance for the Prediction of Hepatic Clearance in the Early Drug Discovery and Development from the in Vitro-to-in Vivo Extrapolation Method and an Approach for Exploring Whether an Albumin-Mediated Hepatic Uptake Phenomenon Could be Present Under in Vivo Conditions.从体外到体内推断方法预测早期药物发现和开发中的肝清除率的新指导以及探索体内条件下是否存在白蛋白介导的肝摄取现象的方法。
J Pharm Sci. 2021 Jul;110(7):2841-2858. doi: 10.1016/j.xphs.2021.04.002. Epub 2021 Apr 20.
5
Next generation risk assessment (NGRA): Bridging in vitro points-of-departure to human safety assessment using physiologically-based kinetic (PBK) modelling - A case study of doxorubicin with dose metrics considerations.下一代风险评估(NGRA):使用基于生理学的动力学(PBK)建模将体外起始点与人类安全评估联系起来——以多柔比星和剂量指标考虑为例。
Toxicol In Vitro. 2021 Aug;74:105171. doi: 10.1016/j.tiv.2021.105171. Epub 2021 Apr 20.
6
Evaluation of Prediction Accuracy for Volume of Distribution in Rat and Human Using In Vitro, In Vivo, PBPK and QSAR Methods.评价使用体外、体内、基于生理的药代动力学和定量构效关系方法预测大鼠和人体分布容积的准确性。
J Pharm Sci. 2021 Apr;110(4):1799-1823. doi: 10.1016/j.xphs.2020.12.005. Epub 2020 Dec 16.
7
Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial.防晒霜应用对防晒霜活性成分血浆浓度的影响:一项随机临床试验。
JAMA. 2020 Jan 21;323(3):256-267. doi: 10.1001/jama.2019.20747.
8
Application of physiologically based kinetic (PBK) modelling in the next generation risk assessment of dermally applied consumer products.生理动力学(PBK)模型在经皮应用消费品下一代风险评估中的应用。
Toxicol In Vitro. 2020 Mar;63:104746. doi: 10.1016/j.tiv.2019.104746. Epub 2019 Dec 16.
9
Towards harmonization of test methods for in vitro hepatic clearance studies.致力于体外肝脏清除研究中检测方法的协调统一。
Toxicol In Vitro. 2020 Mar;63:104722. doi: 10.1016/j.tiv.2019.104722. Epub 2019 Nov 20.
10
Prediction of Fraction Unbound in Microsomal and Hepatocyte Incubations: A Comparison of Methods across Industry Datasets.微粒体和肝细胞孵育中游离分数的预测:行业数据集间方法的比较。
Mol Pharm. 2019 Sep 3;16(9):4077-4085. doi: 10.1021/acs.molpharmaceut.9b00525. Epub 2019 Aug 8.